Avatar

Mild Cognitive Impairment and Risk Factors for Dementia

By Lawrence Robbins 28 Videos
0 views
December 5, 2023
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
03:08
Lilly Medical Affairs

Communicating Amyloid Pathology and Treatment Options to Patients

Feat. R. Perry
03:05
Lilly Medical Affairs

Communicating Treatment Options after a Diagnosis of Alzheimer'…

Feat. S. Cohen
02:59
Lilly Medical Affairs

Providing Patients and Care Partners with Necessary Treatment Inform…

Feat. A. Burke
11:25
Michael Collins

Sports-Related Post-Concussion Syndrome: Risk Profiles and Clinical …

19:54
Anton Porsteinsson

Aducanumab FDA Approval for Alzheimer's Disease: The Importance…

57:45
ACHL

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

Feat. J. Galvin
35:24
University of Miami

Lewy Body Dementia: The Most Common Disease You Never Heard Of

Feat. J. Galvin
30:25
ZINCARE

Cognitive Disorders

Feat. M. Mataa
15:14
Lawrence Robbins

Neuro Exam: Cranial Nerves

17:24
NYU Langone Orthopedic Webinar Series

Sideline Evaluation and Management of the Athlete With a Suspected C…

Feat. D. Cardone
10:52
Children’s Hospital of Philadephia - General Pediatrics

Concussion Pediatric Evaluation

Feat. C. Master
41:59
ZINCARE

Approach to Cognitive Impairment in Adults

Feat. M. Mataa
13:09
UCSF Benioff Children's Hospitals - General Pediatrics

Concussions in Children - Initial Evaluation, Testing and When to Im…

Feat. C. Baker
34:05
Mary Ireland

Sideline Decisions

Feat. M. Ireland
10:54
Josh Bloom

Sports Concussion: Subacute Office Evaluation

26:51
2023 Conference Coverage

Updates in Dementia

Feat. P. Tipton
18:46
Michael Collins

Concussion In-Office Evaluation and Diagnosis

35:39
Providence Swedish

Multiple Sclerosis for the Non-Neurologist

Feat. J. D. Bowen
57:12
Miller Medical Communications

An Update on Alzheimer's Disease: New Strategies Across the Dis…

Feat. P. Tariot
58:23
Alberto Espay

The Illusion of Progress: Lecanemab in Alzheimer's Disease